Artificial Intelligence: Applications in the Field of Immune-Mediated Inflammatory Diseases and Onco-Hematology
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".
Deadline for manuscript submissions: 30 July 2025 | Viewed by 757
Special Issue Editors
Interests: immunodeficiency; autoimmunity; neuro-endocrino-immunology; pharmacogenomics; soluble molecules; immune-mediated diseases; allergies; vaccines
Special Issues, Collections and Topics in MDPI journals
Interests: mediators of inflammation; cytokines; biomarkers of oxidative stress; immunosenescence; immunogenetics; epigenetics; application of machine learning; deep learning in various fields of medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Artificial intelligence (AI) is becoming increasingly interesting and applied in various fields, including the biomedicine. Medicine is particularly involved because techniques based on machine learning (ML) allow us to improve the accuracy of medical diagnoses or to anticipate the outcome of possible therapeutic interventions.
Specifically, ML is utilized in the field of immune-mediated diseases, providing support for the diagnosis of systemic forms, such as systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, and Sjogren's syndrome. It also helps in the early prediction of their involvement within individual viscera (lungs, heart, kidneys, gastrointestinal tract, etc.). For example, the application of AI in patients with systemic sclerosis can lead to an early diagnosis of interstitial lung disease and ILD, anticipating functional signs shown by traditional techniques, such as spirometry and pH impedance analysis.
ML, deep learning (DL), and natural language processing (NLP) techniques hold promise to revolutionize diagnosis and therapy in the onco-hematological field. This is possible thanks to their ability to automatically analyze huge amounts of information in a digital format (clinical data, pathological anatomy, and so-called multiomics data, which concern the circulating immune profile, radiomics, genomics, and RNA sequencing) to characterize neoplasms.
This Special Issue is led by Prof. Dr. Giuseppe Murdaca and Prof. Dr. Sebastiano Gangemi, and assisted by Dr. Francesca Paladin from the Department of Internal Medicine and Medical Specialties (DIMI) at University of Genoa in Genoa, Italy. It aims to collect and analyze the most recent scientific evidence supporting the use of AI in immunology and onco-hematological fields. Both review and research articles are welcome. Please note that pure clinical studies or models are not suitable for this journal; however, clinical submissions with biomolecular studies are welcome.
Prof. Dr. Giuseppe Murdaca
Prof. Dr. Sebastiano Gangemi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- artificial intelligence
- machine learning
- immune-mediated diseases
- cancers
- hematological ma-lignancies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
